Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Stephen Liu

Associate Professor

Georgetown University School of Medicine

United States

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Pharmacotherapy

100%

Pharmacology

100%

Oncology

100%

Cancer Biology

90%

Targeted Therapy

80%

Cancer Therapy

70%

Tyrosine Kinase

70%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles22

Unmet Needs in Maintenance Therapy for Extensive Stage Small Cell Lung Cancer

Article Link

Year:

2025

A First-in-Human Study of cinrebafusp alfa, a HER2/4-1BB Bispecific Molecule, in Patients with HER2-Positive Advanced Solid Malignancies

Article Link

Year:

2024

Real-World Outcomes of First-Line Treatment With Anti–PD(L)1-Based Combination Therapy for Nonsquamous Metastatic Non–Small Cell Lung Cancer: A Multiregional Chart Review in Europe, Japan, and the United States

Article Link

Year:

2024

Real-World Treatment Patterns and Clinical Outcomes After Platinum-Doublet Chemotherapy and Immunotherapy in Metastatic Non–Small Cell Lung Cancer: A Multiregional Chart Review in the United States, Europe, and Japan

Article Link

Year:

2024

Real-world survival of patients treated with taxane therapy after exposure to immunotherapy and platinum-based chemotherapy for advanced non-small-cell lung cancer without actionable mutations

Article Link

Year:

2024

Recent advances and future strategies in first-line treatment of ES-SCLC

Article Link

Year:

2024

Real-world outcomes associated with afatinib use in patients with solid tumors harboring NRG1 gene fusions

Article Link

Year:

2024

SKYSCRAPER-02: Tiragolumab in Combination With Atezolizumab Plus Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer

Article Link

Year:

2024

Long-Term Survival and Stable Disease in a Patient with Extensive-Stage Small-Cell Lung Cancer after Treatment with Carboplatin, Etoposide and Atezolizumab

Article Link

Year:

2024

NRG1 Fusions in NSCLC: Being eNRGy Conscious

Article Link

Year:

2024

Zipalertinib in EGFR Exon 20–Mutant Non–Small-Cell Lung Cancer: Drug Development in a Rare but Crowded Setting

Article Link

Year:

2023

Clinical and molecular characterization of long-term survivors with extensive-stage small cell lung cancer treated with first-line atezolizumab plus carboplatin and etoposide

Article Link

Year:

2023

EGFR Mutations Are Not All the Same: the Importance of Biomarker Testing in Non-small Cell Lung Cancer (NSCLC)—A Podcast Discussion Between Patients and Oncologists

Article Link

Year:

2023

Use of Erdafitinib in FGFR3-Mutated Recurrent Respiratory Papillomatosis

Article Link

Year:

2022

Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients With NTRK Fusion-Positive Solid Tumors

Article Link

Year:

2022

Antibody Drug Conjugates in Lung Cancer: State of the Current Therapeutic Landscape and Future Developments

Article Link

Year:

2021

Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Locally Advanced or Metastatic ROS1 Fusion–Positive Non–Small-Cell Lung Cancer

Article Link

Year:

2021

Divergent RET- and BRAF-Mediated Resistance to Osimertinib in EGFR-Mutant NSCLC: A Case Report

Article Link

Year:

2021

Landscape and Clonal Dominance of Co-occurring Genomic Alterations in Non–Small-Cell Lung Cancer Harboring MET Exon 14 Skipping

Article Link

Year:

2021

NRG1 fusions: Biology to therapy

Article Link

Year:

2021

Novel Cytotoxic Chemotherapies in Small Cell Lung Carcinoma

Article Link

Year:

2021

Tarloxotinib Is a Hypoxia-Activated Pan-HER Kinase Inhibitor Active Against a Broad Range of HER-Family Oncogenes

Article Link

Year:

2021

Collaborators8

Matthew Krebs

Clinical Senior Lecturer

The University of Manchester

UNITED KINGDOM

Joshua Reuss

Assistant Professor of Medicine

UNITED STATES

Paula Pohlmann

The University of Texas MD Anderson Cancer Center

UNITED STATES

Sarina Piha-Paul

Associate Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

Charu Aggarwal

University of Pennsylvania

UNITED STATES

Lyudmila Bazhenova

University of California

UNITED STATES

Marialuisa Lavitrano

Full Professor

University of Milano-Bicocca

ITALY

Adam Patterson

Associate Professor

University of Auckland

NEW ZEALAND

How do I reach out?

Meet Kite AI